Şunu aradınız:: nocturi (Danca - İngilizce)

dysuri, nocturi
dysuria, nocturia

miktionsforstyrrelse, nocturi, øget vandladningsfrekvens
micturition disorder, nocturia, increased urinary frequency

ikke almindelig: dysuri, hyppig vandladning, nocturi.
uncommon: dysuria, micturition urgency, nocturia.

usædvanlig: abnorm urinudskillelse (inklusive dysuri, frekvens, nocturi)
uncommon: pruritus, rash, urticaria, scalp/hair abnormality (including alopecia) renal and urinary disorders:

hyppigheden af indberettet nocturi var den samme for placebo og empagliflozin (<1 %).
the frequency of reported nocturia was similar for placebo and empagliflozin (<1%).

sygdomme i nyrer og urinveje:usædvanlig: abnorm urinudskillelse (inklusive dysuri, frekvens, nocturi)
uncommon: pruritus, rash, urticaria, scalp/hair abnormality (including alopecia) renal and urinary disorders:

akut nyresvigt, nyresvigt, nephrolitiasis, forhøjet kreatinin i blodet, nedsat kreatininclearance i nyrerne, proteinuri, bilirubinuri, dysuri, nocturi, pollakisuri
acute renal failure, renal failure, nephrolithiasis, increased blood creatinine, decreased creatinine renal clearance, proteinuria, bilirubinuria, dysuria, nocturia, pollakiuria

hyppigheden af øget vandladning (inklusive de foruddefinerede betegnelser pollakiuri, polyuri og nocturi) var større hos empagliflozinbehandlede patienter (empagliflozin 10 mg: 3,4 %, empagliflozin 25 mg: 3,2 %) end for placebo (1,0 %).
increased urination (including the predefined terms pollakiuria, polyuria, and nocturia) was observed at higher frequencies in patients treated with empagliflozin (empagliflozin 10 mg: 3.4%, empagliflozin 25 mg: 3.2%) compared to placebo (1.0%).